Ephrin A1 (EFNA1) Peptid
-
- Target Alle Ephrin A1 (EFNA1) Produkte
- Ephrin A1 (EFNA1)
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Verwendungszweck
- Ephrin-A1 (extracellular) Negative Control Antigen
- Sequenz
- (C)KITHSPQAHD NPQEK, correspond ing to amino acid residues 150-164 of human Ephrin-A1 (Accession P20827).
- Produktmerkmale
- Synthetic peptide, A Blocking peptide for Anti-Ephrin-A1 (extracellular) Antibody (ABIN7043128, ABIN7044255 and ABIN7044256)). Intended to be used as a negative control.
- Reinheit
- >70 %
-
-
- Applikationshinweise
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Kommentare
-
Confirmed by amino acid analysis and mass spectrometry.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- 100 μL double distilled water (DDW).
- Lagerung
- RT,-20 °C
- Informationen zur Lagerung
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
- Target
- Ephrin A1 (EFNA1)
- Synonyme
- Xefrin-A1 Peptide, b61 Peptide, ecklg Peptide, efl1 Peptide, efna1 Peptide, efna1a Peptide, elfa-a Peptide, epha1 Peptide, eplg1 Peptide, lerk1 Peptide, tnfaip4 Peptide, xelf-a' Peptide, xelfa Peptide, AI325262 Peptide, B61 Peptide, Efl1 Peptide, Epl1 Peptide, Eplg1 Peptide, Lerk1 Peptide, ECKLG Peptide, EFL1 Peptide, EPLG1 Peptide, LERK-1 Peptide, LERK1 Peptide, TNFAIP4 Peptide, efna1b Peptide, MGC130661 Peptide, ephrin-A1 S homeolog Peptide, ephrin-A1 Peptide, ephrin A1 Peptide, ephrin-A1b Peptide, ephrin-A1 L homeolog Peptide, efna1.S Peptide, efna1 Peptide, EFNA1 Peptide, efna1b Peptide, Efna1 Peptide, efna1.L Peptide
- Gen-ID
- 1942
- NCBI Accession
- NM_004428
- UniProt
- P20827
-